Cytori Therapeutics reported $3.03M in Equity Capital and Reserves for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Baxter International BAX:US $ 8689M 122M
Cerus CERS:US $ 103.81M 5.43M
Cytori Therapeutics CYTX:US $ 3.03M 0.41M
Genocea Biosciences GNCA:US $ 8.98M 11.22M
Haemonetics HAE:US $ 719.15M 51.23M
Infinity Pharmaceuticals INFI:US $ -14.13M 2.74M
Mirati Therapeutics MRTX:US $ 1360.79M 809.85M
Starpharma Holdings Ltd SPL:AU 69.76M 38.43M
Sunesis Pharmaceuticals SNSS:US $ 19.94M 4.53M
Teva Pharmaceutical TEVA:IT 10.03B 433M